These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2948509)

  • 1. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome.
    Bazan NG; Scott BL; Reddy TS; Pelias MZ
    Biochem Biophys Res Commun; 1986 Dec; 141(2):600-4. PubMed ID: 2948509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II.
    Maude MB; Anderson EO; Anderson RE
    Invest Ophthalmol Vis Sci; 1998 Oct; 39(11):2164-6. PubMed ID: 9761296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Possible role of altered levels of plasma docosahexaenoic acid in the pathogenesis of retinitis pigmentosa. Preliminary results].
    Simonelli F; Milone A; Iura A; Picardi C; La Banca AM; Cotticelli L; Rinaldi E
    Boll Soc Ital Biol Sper; 1990 Sep; 66(9):893-8. PubMed ID: 2149985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal plasma levels of polyunsaturated fatty acid in autosomal dominant retinitis pigmentosa.
    Anderson RE; Maude MB; Lewis RA; Newsome DA; Fishman GA
    Exp Eye Res; 1987 Jan; 44(1):155-9. PubMed ID: 2951269
    [No Abstract]   [Full Text] [Related]  

  • 5. A new clinical classification for Usher's syndrome based on a new subtype of Usher's syndrome type I.
    Otterstedde CR; Spandau U; Blankenagel A; Kimberling WJ; Reisser C
    Laryngoscope; 2001 Jan; 111(1):84-6. PubMed ID: 11192904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega 3 and omega 6 fatty acids on transformation of cultured cells by irradiation and transfection.
    Takahashi M; Przetakiewicz M; Ong A; Borek C; Lowenstein JM
    Cancer Res; 1992 Jan; 52(1):154-62. PubMed ID: 1530767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal sperm and photoreceptor axonemes in Usher's syndrome.
    Hunter DG; Fishman GA; Mehta RS; Kretzer FL
    Arch Ophthalmol; 1986 Mar; 104(3):385-9. PubMed ID: 3954639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usher's syndrome type IC: clinical studies and fine-mapping the disease locus.
    Marietta J; Walters KS; Burgess R; Ni L; Fukushima K; Moore KC; Hejtmancik JF; Smith RJ
    Ann Otol Rhinol Laryngol; 1997 Feb; 106(2):123-8. PubMed ID: 9041816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain.
    Spector AA
    J Mol Neurosci; 2001; 16(2-3):159-65; discussion 215-21. PubMed ID: 11478370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usher's syndrome type 3 in Finland.
    Pakarinen L; Karjalainen S; Simola KO; Laippala P; Kaitalo H
    Laryngoscope; 1995 Jun; 105(6):613-7. PubMed ID: 7769945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonate and docosahexaenoate added to infant formula influence fatty acid composition and subsequent eicosanoid production in neonatal pigs.
    Huang MC; Craig-Schmidt MC
    J Nutr; 1996 Sep; 126(9):2199-208. PubMed ID: 8814208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidence of Usher's syndrome and its clinical types].
    Bereketoğlu M; Avşar EU; Turan O; Afrashi F; Apaydin F
    Kulak Burun Bogaz Ihtis Derg; 2002; 9(1):15-20. PubMed ID: 12122620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labeling of lipids of retina subcellular fractions by [1-14C]eicosatetraenoate (20:4(n-6)) docosapentaenoate (22:5(n-3)) and docosahexaenoate (22:6(n-3)).
    Rotstein NP; Aveldaño MI
    Biochim Biophys Acta; 1987 Sep; 921(2):221-34. PubMed ID: 2958089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active labeling of phosphatidylcholines by [1-14C]docosahexaenoate in isolated photoreceptor membranes.
    Guisto NM; de Boschero MI; Sprecher H; Aveldaño MI
    Biochim Biophys Acta; 1986 Aug; 860(1):137-48. PubMed ID: 2942188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylation of docosahexaenoic acid into phospholipids by intact human neutrophils.
    Tou JS
    Lipids; 1986 May; 21(5):324-7. PubMed ID: 2941637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of supplementation of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemostatic function in healthy subjects.
    Hirai A; Terano T; Takenaga M; Kobayashi S; Makuta H; Ozawa A; Fujita T; Tamura Y; Kitagawa H; Kumagai A
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():838-45. PubMed ID: 2823571
    [No Abstract]   [Full Text] [Related]  

  • 17. Docosahexaenoic acid metabolism and inherited retinal degenerations.
    Bazan NG; Scott BL
    Prog Clin Biol Res; 1987; 247():103-18. PubMed ID: 2891142
    [No Abstract]   [Full Text] [Related]  

  • 18. Postural control in blinds and in Usher's syndrome.
    Pyykkö I; Vesikivi M; Ishizaki H; Magnusson M; Juhola M
    Acta Otolaryngol Suppl; 1991; 481():603-6. PubMed ID: 1927482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A longitudinal study of plasma n-3 fatty acid levels in a family with X-linked retinitis pigmentosa.
    McLachlan T; McColl AJ; Collins MF; Converse CA; Packard CJ; Shepherd J
    Biochem Soc Trans; 1990 Oct; 18(5):905-6. PubMed ID: 2150655
    [No Abstract]   [Full Text] [Related]  

  • 20. Usher's syndrome.
    Samuelson S; Zahn J
    Ophthalmic Paediatr Genet; 1990 Mar; 11(1):71-6. PubMed ID: 2190135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.